When should patients with kidney disease be evaluated for dyslipidemia?
Recent guidelines from the Kidney Disease Improving Global Outcomes (KDIGO) have recommended that all adult patients with newly identified CKD, including those on dialysis or kidney transplant recipients, should be evaluated with a lipid profile. Although the evidence to suggest improved clinical outcomes after measuring lipids is lacking, the risks of testing are low, and the data may provide information on cardiovascular disease (CVD) prognosis and guide treatment.
